相关实验视频

Updated: May 28, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

在宫癌中识别差异表达的MiRNA集群

S Sriharikrishnaa¹, Padacherri Vethil Jishnu¹, Vinay Koshy Varghese¹

¹Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

Discover oncology

|February 13, 2025

概括

异常的微RNA集群 (MCs) 与子宫癌 (CC) 的进展有关. 这项研究确定了特定的MC,它们的预后价值和治疗目标,为CC管理提供了新的途径.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

异常的微RNA (miRNA) 表达与宫癌 (CC) 的进展有关.
识别特定的miRNA集群 (MCs) 及其作用对于理解CC发展至关重要.

研究的目的:

为了识别宫癌中改变的miRNA集群 (MCs).
确定这些MC的临床效用和生物功能.
探索它们作为CC管理中的生物标志物和治疗点的潜力.

主要方法:

小RNA测序和qRT-PCR被用于识别和验证椎状细胞癌 (CSCC) 中差异表达的MCs.
计算工具预测了已识别的MC的潜在目标,途径,生物功能和临床实用性.
分析了公开可用的CC数据集以进行交叉验证.

主要成果:

在48个MCs内的229个miRNAs在CSCC中显著差异地表达.
证实了hsa-miR-376c-3p,hsa-miR-494-3p,hsa-miR-495-3p和hsa-miR-409-3p的降低调节情况.
一个预后模型在预测整体存活率方面表现出强大的灵敏度 (0.88-0.92),确定了22个具有预后意义的miRNAs.
途径分析强调了与癌症相关的途径 (例如,p53,细胞循环,MAPK信号传递) 的丰富.
确定了顶级基因标和药物基因相互作用,表明了治疗潜力.

结论:

该研究成功地确定了与宫癌相关的关键miRNA集群 (MCs).
这些MC及其向基因在CC中显示出显著的预后效用和潜在功能.
这些发现支持在CC管理和治疗策略中使用这些MC.

关键词:

生物信息学是一种生物信息学.宫癌是发生在宫癌的原因之一.药物基因相互作用药物基因相互作用地理地质组织 (GEO) 是指地理地质组织.基因存在学基因存在学一个MiRNA集群.

更多相关视频

Isolation of Small Noncoding RNAs from Human Serum

Isolation of Small Noncoding RNAs from Human Serum

Published on: June 19, 2014

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...